Cartesian Therapeutics Inc

Cartesian Therapeutics’ RNA cell therapy offers a breakthrough for autoimmune disease, but falling stock, negative P/E and hefty R&D costs keep investors wary.

Cartesian Therapeutics, Inc. is a biotech company pioneering RNA cell therapy to treat autoimmune diseases, offering a potential cure and transforming the lives of millions of patients worldwide.